Matrixx Zicam “Cold Monster” Campaign Claims Fail NAD Test
This article was originally published in The Tan Sheet
Executive Summary
NAD recommends Matrixx discontinue using “Don’t let a monster of a cold catch you” in print and online ads because the claims “could reasonably be understood by consumers” to mean Zicam products prevent colds. ProPhase Labs, maker of the rival zinc-containing homeopathic Cold-EEZE line, challenges the Zicam ads.
You may also be interested in...
Zicam Creates A Monster With Reanimated Brand
Matrixx aims to make more consumers aware they can shorten the duration of a cold rather than treat the symptoms without affecting how long the cold lasts. New advertising introduces the “Cold Monster” to remind consumers to use Zicam products when they feel the first signs of a “monster of a cold.”
Matrixx Rejected On ProPhase Labs Bid, Picks Up Option On Shares
In a bid to dominate the market for zinc cold remedies, Matrixx Initiatives attempts to acquire ProPhase Labs, but is turned away by CEO Ted Karkus who asserts ProPhase’s growth prospects outweigh the benefits of a sale.
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.